Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-09

Clinical Trial Update: Simvastatin Effect on Portal Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating simvastatin for portal hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Universidade Federal do Rio de Janeiro | Conditions: Portal Hypertension, Esophageal Varices | Phase 3 | Status: COMPLETED